Cullinan Oncology, Inc. - stock earnings
CGEM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -23.8 million USD | ? USD |
| 2023Q3 | -39.2 million USD | ? USD |
| 2023Q2 | -32.2 million USD | ? USD |
| 2023Q1 | -58.0 million USD | ? USD |
| 2022Q4 | -27.1 million USD | ? USD |
| 2022Q3 | -24.9 million USD | ? USD |
| 2022Q2 | 174.9 million USD | ? USD |
| 2022Q1 | -12.9 million USD | ? USD |
| 2021Q4 | -32.5 million USD | -37.8 million USD |
| 2021Q3 | -17.4 million USD | ? USD |
| 2021Q2 | -15.6 million USD | ? USD |
| 2021Q1 | -70000 USD | 18.9 million USD |
| 2020Q4 | -28.3 million USD | ? USD |
| 2020Q3 | -9.9 million USD | ? USD |
| 2020Q2 | -8.6 million USD | ? USD |
| 2020Q1 | -5.0 million USD | ? USD |
| 2019Q4 | -4.6 million USD | ? USD |
| 2016Q4 | -72524 USD | ? USD |
| 2016Q3 | -20277 USD | ? USD |
| 2016Q2 | -146532 USD | ? USD |
| 2016Q1 | -77370 USD | ? USD |
| 2015Q4 | -42846 USD | ? USD |
| 2015Q3 | -26763 USD | ? USD |
CGEM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -153.2 million USD | ? USD |
| 2022 | 111.2 million USD | ? USD |
| 2021 | -65.0 million USD | 18.9 million USD |
| 2020 | -50.8 million USD | 18.9 million USD |
| 2019 | -20.0 million USD | ? USD |
| 2018 | -14.2 million USD | ? USD |
| 2016 | -316703 USD | ? USD |
| 2015 | -109510 USD | ? USD |
| 2014 | -130537 USD | ? USD |
| 2013 | -704663 USD | ? USD |
CGEM
Price: $27.58
52 week price:
Earnings Per Share: -3.69 USD
P/E Ratio: -4.79
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 351200
Market Capitalization: 733.0 million